Depression and chronic kidney disease: A review for clinicians

Australian and New Zealand Journal of Psychiatry

Volumn 48, Issue 6, 2014, Pages 530-541

  Bautovich, Alison ^a,b,c   Katz, Ivor ^a,c   Smith, Michelle ^a,d   Loo, Colleen K ^a,c,e   Harvey, Samuel B ^a,c,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b The New South Wales Institute of Psychiatry   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e BLACK DOG INSTITUTE   (Australia)

Author keywords

Antidepressive agents; Depression; Dialysis; Kidney disease; Mental illness; Renal failure

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; FLUOXETINE; MIRTAZAPINE; PAROXETINE; PHENELZINE; VENLAFAXINE; SERTRALINE;

BLOOD DYSCRASIA; BLURRED VISION; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COGNITIVE THERAPY; CONFUSION; DEPRESSION; DIALYSIS; DIARRHEA; DISEASE ASSOCIATION; DROWSINESS; DYSPEPSIA; EDEMA; ELECTROCONVULSIVE THERAPY; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPERTENSIVE CRISIS; HYPONATREMIA; INSOMNIA; KIDNEY DISEASE; KIDNEY FAILURE; MENTAL DISEASE; MOOD DISORDER; MORTALITY; NAUSEA; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PREVALENCE; QUALITY OF LIFE; REVIEW; SCREENING; SEXUAL DYSFUNCTION; URINE RETENTION; XEROSTOMIA; CHRONIC KIDNEY FAILURE; COMPLICATION; PSYCHOLOGY; ANXIETY DISORDER; BECK DEPRESSION INVENTORY; BLEEDING; BODY WEIGHT DISORDER; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; CLINICAL FEATURE; DEPRESSION ASSESSMENT; DSM-IV-TR; EXERCISE; FAMILY COUNSELING; HEADACHE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HYPERTENSION; INCREASED APPETITE; MARITAL THERAPY; QT PROLONGATION; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; RESTLESSNESS; SEDATION; SOCIAL SUPPORT; SWEAT GLAND DISEASE; SYSTEMATIC REVIEW; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT REFUSAL;

DEPRESSION; HUMANS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84903536365     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867414528589     Document Type: Review

References (96)

1. Ahrens T, Deuschle M, Krumm B, et al. (2008) Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosomatic Medicine 70: 461-467.
2. Ancarani E, Biondi B, Bolletta A, et al. (1993) Major depression complicating hemodialysis in patients with chronic renal failure: A multicenter, double blind, controlled clinical trial of S-adenosyl-lmethionine versus placebo. Current Therapeutic Research, Clinical and Experimental 54: 680-686.
3. Anderson RJ, Freedland KE, Clouse RE, et al. (2001) The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 24: 1069-1078.
4. Baghdady NT, Banik S, Swartz SA, et al. (2009) Psychotropic drugs and renal failure: Translating the evidence for clinical practice. Advances in Therapy 26: 404-424.
5. Baines LS, Joseph JT and Jindal RM (2004) Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants. Kidney International 65: 1937-1942.
6. Beck AT, Epstein N, Brown G, et al. (1988) An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology 56: 893-897.
7. Berkman LF, Blumenthal J, Burg M, et al. (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289: 3106-3116.
8. Berlim MT, Van den Eynde F and Daskalakis ZJ (2013) Clinical utility of transcranial direct current stimulation (tDCS) for treating major depression: A systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Journal of Psychiatric Research 47: 1-7.
9. Blumenfield M, Levy NB, Spinowitz B, et al. (1997) Fluoxetine in depressed patients on dialysis. International Journal of Psychiatry in Medcine 27: 71-80.
10. Brewster UC, Ciampi MA, Abu-Alfa AK, et al. (2003) Addition of sertraline to other therapies to reduce dialysis-associated hypotension. Nephrology (Carlton) 8: 296-301.
11. Bril V, England J, Franklin GM, et al. (2011) Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PM & R 3: 345-352, 352.e1-21.
12. Carney S, Cowen P, Geddes J, et al. (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet 361: 799-808.
13. Chan R, Brooks R, Erlich J, et al. (2009) The effects of kidney-diseaserelated loss on long-term dialysis patients' depression and quality of life: Positive affect as a mediator. Clinical Journal of the American Society of Nephrology 4: 160-167.
14. Chilcot J, Davenport A, Wellsted D, et al. (2011) An association between depressive symptoms and survival in incident dialysis patients. Nephrology, Dialysis, Transplantation 26: 1628-1634.
15. Chilcot J, Wellsted D and Farrington K (2010) Depression in end-stage renal disease: Current advances and research. Seminars in Dialysis 23: 74-82.
16. Cohen LM, Tessier EG, Germain MJ, et al. (2004) Update on psychotropic medication use in renal disease. Psychosomatics 45: 34-48.
17. Daneker B, Kimmel PL, Ranich T, et al. (2001) Depression and marital dissatisfaction in patients with end-stage renal disease and in their spouses. American Journal of Kidney Diseases 38: 839-846.
18. De Godoy DV and de Godoy RF (2003) A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Archives of Physical Medicine and Rehabilitation 84: 1154-1157.
19. DeVane CL, Liston HL and Markowitz JS (2002) Clinical pharmacokinetics of sertraline. Clinical Pharmacokinetics 41: 1247-1266.
20. Dowlati Y, Herrmann N, Swardfager W, et al. (2010) A meta-analysis of cytokines in major depression. Biological Psychiatry 67: 446-457.
21. Doyle GD, Laher M, Kelly JG, et al. (1989) The pharmacokinetics of paroxetine in renal impairment. Acta Psychiatrica Scandinavica. Supplementum 350: 89-90.
22. Duarte PS, Miyazaki MC, Blay SL, et al. (2009) Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney International 76: 414-421.
23. Farrokhi F (2012) Depression among dialysis patients: Barriers to good care. Iranian Journal of Kidney Diseases 6: 403-406.
24. Feroze U, Martin D, Reina-Patton A, et al. (2010) Mental health, depression, and anxiety in patients on maintenance dialysis. Iranian Journal of Kidney Diseases 4: 173-180.
25. Fiest KM, Dykeman J, Patten SB, et al. (2013) Depression in epilepsy: A systematic review and meta-analysis. Neurology 80: 590-599.
26. Greenwood SA, Lindup H, Taylor K, et al. (2012) Evaluation of a pragmatic exercise rehabilitation programme in chronic kidney disease. Nephrology, Dialysis, Transplantation 27 Suppl 3: iii126-134.
27. Group FHNT, Chertow GM, Levin NW, et al. (2010) In-center hemodialysis six times per week versus three times per week. New England Journal of Medicine 363: 2287-2300.
28. Guzman SJ and Nicassio PM (2003) The contribution of negative and positive illness schemas to depression in patients with end-stage renal disease. Journal of Behavioral Medicine 26: 517-534.
29. Halen NV, Cukor D, Constantiner M, et al. (2012) Depression and mortality in end-stage renal disease. Current Psychiatry Reports 14: 36-44.
30. Harvey SB and Ismail K (2008) Psychiatric aspects of chronic physical disease. Medicine 36: 471-474.
31. Harvey SB, Glozier N, Henderson M, et al. (2011) Depression and work performance: An ecological study using web-based screening. Occupational Medicine 61: 209-211.
32. Harvey SB, Hotopf M, Overland S, et al. (2010) Physical activity and common mental disorders. British Journal of Psychiatry 197: 357-364.
33. Hatch SL, Harvey SB and Maughan B (2010) A developmental-contextual approach to understanding mental health and well-being in early adulthood. Social Science & Medicine 70: 261-268.
34. Hedayati SS and Finkelstein FO (2009) Epidemiology, diagnosis, and management of depression in patients with CKD. American Journal of Kidney Diseases 54: 741-752.
35. Hedayati SS, Bosworth HB, Briley LP, et al. (2008) Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney International 74: 930-936.
36. Hedayati SS, Bosworth HB, Kuchibhatla M, et al. (2006) The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney International 69: 1662-1668.
37. Hedayati SS, Grambow SC, Szczech LA, et al. (2005) Physiciandiagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. American Journal of Kidney Diseases 46: 642-649.
38. Hedayati SS, Minhajuddin AT, Afshar M, et al. (2010) Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA 303: 1946-1953.
39. Hedayati SS, Yalamanchili V and Finkelstein FO (2012) A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney International 81: 247-255.
40. Himmelfarb J (2008) Oxidative stress in hemodialysis. Contributions to Nephrology 161: 132-137.
41. Horton WA and Fergusson NV (1988) Hyperkalaemia and cardiac arrest after the use of suxamethonium in intensive care. Anaesthesia 43: 890-891.
42. Hosseini SH, Espahbodi F and Mirzadeh Goudarzi SM (2012) Citalopram versus psychological training for depression and anxiety symptoms in hemodialysis patients. Iranian Journal of Kidney Diseases 6: 446-451.
43. Howren MB, Lamkin DM and Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine 71: 171-186.
44. Jaber BL, Lee Y, Collins AJ, et al. (2010) Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: Interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. American Journal of Kidney Diseases 56: 531-539.
45. Katon WJ (2011) Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues in Clinical Neuroscience 13: 7-23.
46. Kaveh K and Kimmel PL (2001) Compliance in hemodialysis patients: Multidimensional measures in search of a gold standard. American Journal of Kidney Diseases 37: 244-266.
47. Kelly CA, Upex A, Spencer EP, et al. (2003) Adult respiratory distress syndrome and renal failure associated with citalopram overdose. Human & Experimental Toxicology 22: 103-105.
48. Kimmel PL (2000) Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: Correlates and outcomes. American Journal of Kidney Diseases 35: S132-140.
49. Kimmel PL, Peterson RA, Weihs KL, et al. (1998a) Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney International 54: 245-254.
50. Kimmel PL, Peterson RA, Weihs KL, et al. (2000) Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney International 57: 2093-2098.
51. Kimmel PL, Phillips TM, Simmens SJ, et al. (1998b) Immunologic function and survival in hemodialysis patients. Kidney International 54: 236-244.
52. Knudsen AK, Harvey SB, Mykletun A, et al. (2013) Common mental disorders and long-term sickness absence in a general working population. The Hordaland Health Study. Acta Psychiatrica Scandinavica 127: 287-297.
53. Koo JR, Yoon JW, Kim SG, et al. (2003) Association of depression with malnutrition in chronic hemodialysis patients. American Journal of Kidney Diseases 41: 1037-1042.
54. Koo JR, Yoon JY, Joo MH, et al. (2005) Treatment of depression and effect of antidepression treatment on nutritional status in chronic hemodialysis patients. The American Journal of the Medical Sciences 329: 1-5.
55. Kouidi E, Karagiannis V, Grekas D, et al. (2010) Depression, heart rate variability, and exercise training in dialysis patients. European Journal of Cardiovascular Prevention and Rehabilitation 17: 160-167.
56. Kugler C, Vlaminck H, Haverich A, et al. (2005) Nonadherence with diet and fluid restrictions among adults having hemodialysis. Journal of Nursing Scholarship 37: 25-29.
57. Lacson E Jr, Li NC, Guerra-Dean S, et al. (2012) Depressive symptoms associate with high mortality risk and dialysis withdrawal in incident hemodialysis patients. Nephrology, Dialysis, Transplantation 27: 2921-2928.
58. Leggat JE Jr (2005) Adherence with dialysis: A focus on mortality risk. Seminars in Dialysis 18: 137-141.
59. Levy NB, Blumenfield M, Beasley CM Jr, et al. (1996) Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. General Hospital Psychiatry 18: 8-13.
60. Lii YC, Tsay SL and Wang TJ (2007) Group intervention to improve quality of life in haemodialysis patients. Journal of Clinical Nursing 16: 268-275.
61. Lloyd GG and Guthrie E (2007) Handbook of Liaison Psychiatry. New York: Cambridge University Press.
62. Loo CK, Sachdev P, Martin D, et al. (2010) A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. The International Journal of Neuropsychopharmacology 13: 61-69.
63. Lopes AA, Bragg J, Young E, et al. (2002) Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney International 62: 199-207.
64. Lorant V, Deliege D, Eaton W, et al. (2003) Socioeconomic inequalities in depression: A meta-analysis. American Journal of Epidemiology 157: 98-112.
65. McDade-Montez EA, Christensen AJ, Cvengros JA, et al. (2006) The role of depression symptoms in dialysis withdrawal. Health Psychology 25: 198-204.
66. Mapes DL, Lopes AA, Satayathum S, et al. (2003) Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney International 64: 339-349.
67. Maratos AS, Gold C, Wang X, et al. (2008) Music therapy for depression. The Cochrane Database of Systematic Reviews CD004517.
68. Mitchell AJ, Chan M, Bhatti H, et al. (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology 12: 160-174.
69. Olver JS and Hopwood MJ (2012) Depression and physical illness. Medical Journal of Australia 1 Suppl 4: 9-12.
70. Ouzouni S, Kouidi E, Sioulis A, et al. (2009) Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Clinical Rehabilitation 23: 53-63.
71. Palmer SC, Vecchio M, Craig JC, et al. (2013b) Association between depression and death in people with CKD: A meta-analysis of cohort studies. American Journal of Kidney Diseases 62: 493-505.
72. Palmer S, Vecchio M, Craig JC, et al. (2013a) Prevalence of depression in chronic kidney disease: Systematic review and meta-analysis of observational studies. Kidney International 84: 179-191.
73. Preljevic VT, Osthus TB, Sandvik L, et al. (2012) Screening for anxiety and depression in dialysis patients: Comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory. Journal of Psychosomatic Research 73: 139-144.
74. Raison CL, Capuron L and Miller AH (2006) Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology 27: 24-31.
75. Rasmussen KG, Sampson SM and Rummans TA (2002) Electroconvulsive therapy and newer modalities for the treatment of medication-refractory mental illness. Mayo Clinic Proceedings 77: 552-556.
76. Rayner L, Price A, Evans A, et al. (2010) Antidepressants for depression in physically ill people. The Cochrane Database of Systematic Reviews CD007503.
77. Rivenes AC, Harvey SB and Mykletun A (2009) The relationship between abdominal fat, obesity and common mental disorders: Results from the HUNT Study. Journal of Psychosomatic Research 66: 269-275.
78. Rosenthal Asher D, Ver Halen N and Cukor D (2012) Depression and nonadherence predict mortality in hemodialysis treated end-stage renal disease patients. Hemodialysis International 16: 387-393.
79. Safren SA, Gonzalez JS, Wexler DJ, et al. (2014) A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care 37: 625-633.
80. Slotema CW, Blom JD, Hoek HW, et al. (2010) Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. Journal of Clinical Psychiatry 71: 873-884.
81. Soni RK, Weisbord SD and Unruh ML (2010) Health-related quality of life outcomes in chronic kidney disease. Current Opinion in Nephrology and Hypertension 19: 153-159.
82. Stenvinkel P and Alvestrand A (2002) Inflammation in end-stage renal disease: Sources, consequences, and therapy. Seminars in Dialysis 15: 329-337.
83. Stenvinkel P, Ketteler M, Johnson RJ, et al. (2005) IL-10, IL-6, and TNFalpha: Central factors in the altered cytokine network of uremia-The good, the bad, and the ugly. Kidney International 67: 1216-1233.
84. Taylor D, Paton C and Kapur S (eds) (2012) Use of psychotropic drugs in special patient groups: Renal Impairment. In: The South London and Maudsley NHS Foundation Trust Oxleas NHS Foundation Trust Prescribing Guidelines in Psychiatry, 11th Edition. Chichester: Wiley-Blackwell, pp.462.
85. Thombs BD, Bass EB, Ford DE, et al. (2006) Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine 21: 30-38.
86. Tyring S, Gottlieb A, Papp K, et al. (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebocontrolled randomised phase III trial. Lancet 367: 29-35.
87. Varghese ST, Sagar R and Jhanjee S (2006) Chronic renal failure and electroconvulsive therapy. Indian Journal of Medical Sciences 60: 114-115.
88. Vazquez I, Valderrabano F, Fort J, et al. (2005) Psychosocial factors and health-related quality of life in hemodialysis patients. Quality of Life Research 14: 179-190.
89. Watnick S, Kirwin P, Mahnensmith R, et al. (2003) The prevalence and treatment of depression among patients starting dialysis. American Journal of Kidney Diseases 41: 105-110.
90. Weiner S, Kutner NG, Bowles T, et al. (2010) Improving psychosocial health in hemodialysis patients after a disaster. Social Work in Health Care 49: 513-525.
91. Weisbord SD, Fried LF, Arnold RM, et al. (2005) Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. Journal of the American Society for Nephrology 16: 2487-2494.
92. Williams S and Ostroff R (2005) Chronic renal failure, hemodialysis, and electroconvulsive therapy: A case report. The Journal of ECT 21: 41-42.
93. Yuan Y, Tsoi K and Hunt RH (2006) Selective serotonin reuptake inhibitors and risk of upper GI bleeding: Confusion or confounding? American Journal of Medicine 119: 719-727.
94. Zalai D, Szeifert L and Novak M (2012) Psychological distress and depression in patients with chronic kidney disease. Seminars in Dialysis 25: 428-438.
95. Zhang MW, Ho RC, Cheung MW, et al. (2011) Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: A systematic review, meta-analysis and meta-regression. General Hospital Psychiatry 33: 217-223.
96. Zunszain PA, Hepgul N and Pariante CM (2013) Inflammation and depression. Current Topics in Behavioral Neurosciences 14: 135-151.